Juvenile Arthritis News

Patients with juvenile idiopathic arthritis have a higher prevalence of celiac disease than those without the disease, according to a short report published in Pediatric Rheumatology.

Patients with autoimmune rheumatic diseases who are undergoing elective hip or knee arthroplasty should maintain their usual doses of methotrexate, leflunomide, hydroxychloroquine, sulfasalazine and apremilast , according to new guidelines.

Children with juvenile idiopathic arthritis who require TNF inhibitors often experience insurance-led delays to therapy initiation, according to a research letter published in JAMA Network Open.

Guiding patients with juvenile dermatomyositis from pediatric to adult care is essential to minimize comorbidities and complications, according to data presented at EULAR 2022 Congress.

Peer-reviewed papers on pediatric antiphospholipid syndrome do not appear very often.

United Rheumatology and CreakyJoints have announced a partnership to launch the Rheumatoid Arthritis Wellness Center, a digital resource that aims to offer support to patients living with RA, according to a press release.

Adolescents experience longer wait times to see a pediatric rheumatologist for juvenile idiopathic arthritis, compared with younger children, according to research published in the Journal of Rheumatology.

Children and adolescents with rheumatic and musculoskeletal diseases who contract COVID-19 are not likely to require hospitalization, according to data published in the Annals of the Rheumatic Diseases.

Joint replacement in patients with inflammatory arthritis is often beset with pitfalls like disease flares and infectious complications, and up until recently, the emergence new treatments were rendering the current guidelines outdated.

Older children and those with ferritin levels greater than 500 µg/L are at highest risk for severe multisystem inflammatory syndrome in children resulting in ICU admission after COVID-19, according to data published in CMAJ.